¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mean target dose"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • daily mean
    ÇÏ·çÆò±ÕÄ¡
  • geometric mean
    ±âÇÏÆò±Õ
  • mean
    1. Æò±Õ 2. Æò±Õ°ª
  • mean arterial blood pressure
    Æò±Õµ¿¸Æ¾Ð
  • mean blood pressure
    Æò±ÕÇ÷¾Ð
  • mean corpuscular constant
    Æò±ÕÀûÇ÷±¸»ó¼ö
  • mean corpuscular diameter
    Æò±ÕÀûÇ÷±¸Áö¸§
  • mean corpuscular hemoglobin
    Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò·®
  • mean corpuscular hemoglobin concentration
    Æò±ÕÀûÇ÷±¸Çì¸ð±Û·Îºó³óµµ
  • mean corpuscular volume
    Æò±ÕÀûÇ÷±¸¿ëÀû
  • mean life expectancy
    Æò±Õ¿©¸í
  • mean life span
    Æò±Õ¼ö¸í
  • mean platelet volume
    Æò±ÕÇ÷¼ÒÆÇ¿ëÀû
  • mean solar day
    Æò±ÕžçÀÏ
  • mean tidal time
    Æò±Õ¼øÈ¯½Ã°£
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • radiation absorbed dose
    Èí¼ö¼±·®
  • skin dose
    ÇǺμ±·®
  • therapeutic dose
    Ä¡·á¿ë·®, Ä¡·á¼±·®
  • high-dose
    °í¿ë·®
  • dose-response relationship
    ¿ë·®¹ÝÀÀ°ü°è
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • target sign
    Ç¥Àû¡ÈÄ
  • target
    Ç¥Àû
  • arithmetic mean
    »ê¼úÆò±Õ
  • mean corpuscular constant
    Æò±ÕÀûÇ÷±¸»ó¼ö
  • mean corpuscular hemoglobin concentration
    Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò³óµµ
  • mean venous oxygen content
    Æò±ÕÁ¤¸ÆÇ÷»ê¼Ò·®
  • daily mean
    ÀÏÆò±ÕÄ¡
  • mean deviation
    Æò±ÕÆíÂ÷
  • mean corpuscular diameter
    Æò±ÕÀûÇ÷±¸Áö¸§
  • mean solar day
    Æò±ÕžçÀÏ
  • root mean square deviation
    Á¦°ö±ÙÆò±ÕÁ¦°öÆíÂ÷
  • mean life expectancy
    Æò±Õ¿©¸í
  • geometric mean
    ±âÇÏÆò±Õ
  • mean corpuscular hemoglobin
    Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò·®
  • mean
    Æò±Õ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • population mean
    ¸ðÆò±Õ(ËḬ̂˻).
  • progressive mean
    ´©°¡Æò±Õ(ËÈ˧̰˻).
  • ED 50=£¾effective dose 50%
    50% À¯È¿·®, Áß°£À¯È¿·®.
  • ED 50=£¾effective dose 50%
    50% À¯È¿·®.
  • ED 50=ÊÝeffective dose 50%
    50% À¯È¿·®.
  • ED=ÊÝeffective dose
    À¯È¿·®.
  • ID50 (50% infectious dose)
    50% °¨¿°·®
  • LD = lethal dose
    Ä¡»ç·®.
  • LD50 (50% lethal dose)
    50% Ä¡»ç·®
  • LD= lethal dose
    Ä¡»ç·®.
  • MED => minimum effective dose
    ÃÖ¼ÒÈ«¹Ý·®
  • MED=> minimum effective dose
    ÃÖ¼ÒÀ¯È¿·®.
  • MED=£¾minimum effective dose
    ÃÖ¼ÒÀ¯È¿·®.
  • MTD=> maximum toderance dose
    ÃÖ´ë³»¿ë·®.
  • MTD=£¾maximum tolerance dose
    ÃÖ´ë³»¿ë·®.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • accommodative target
    Á¶ÀýÀ¯¹ß½ÃÇ¥
  • cell, target
    Ç¥Àû¼¼Æ÷
  • clinical target volume, CTV
    ÀÓ»óÇ¥ÀûüÀû
  • codocyte= target cell
    Ç¥Àû¼¼Æ÷
  • fusional target
    À¶ÇÕÇ¥Áö
  • leptocytes = target cell
    Ç¥Àû»óÀûÇ÷±¸= Ç¥Àû¼¼Æ÷
  • planning target volume
    °èȹ¿ë Ç¥ÀûºÎÇÇ
  • radiation,target theory of
    ¡­ÀÇ Ç¥ÀûÀÌ·Ð(¡­øöîÜìµÖå)
  • single target multi-hit model
    ´ÜÀÏÇ¥Àû´Ù¹ßÀûÁß ¸ðµ¨
  • source-target distance, STD
    ¼±¿øÇ¥Àû°£°Å¸®
  • target
    Ç¥Àû(øöîÜ)
  • target cell
    Ç¥Àû¼¼Æ÷
  • target cell anemia
    Ç¥ÀûÀûÇ÷±¸¼º ºóÇ÷(øöîÜ îåúìϹàõÞ¸úì).
  • target cell anemia
    Ç¥ÀûÀûÇ÷?úÔºóÇ÷(øöîÜ îåúìϹàõÞ¸úì)
  • target configuration
    °ú³á ¸ð¾ç (Ç¥Àû¸ð¾ç)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • standard error of the mean
    Æò±ÕÄ¡ Ç¥ÁØ¿ÀÂ÷ (øÁгö·øöñÞè¦ó¬)
  • absorbed dose
    Èí¼ö·® (ýåâ¥Õá)
  • air dose
    ´ë±â¼±·®(ÓÞѨàÊÕá)
  • booster dose
    ºÎ½ºÅÍ ·®(Õá)
  • dose-response curve
    ¿ë·®´ëÀÀ °î¼±(é»ÕáÓßëëÍØàÊ)
  • exposure dose
    ³ëÃâ·®(ÖÚõóÕá)
  • fractionated dose
    ºÐÇÒ·®(ÝÂùÜÕá)
  • half-value dose
    ¹Ý(Úâ)°ª ¼±·®(àÊÕá)
  • lethal dose
    Ä¡»ç·®(öÈÞÝÕá)
  • maximum permissible dose
    ÃÖ´ëÇã¿ë·®(õÌÓÞúÉé»Õá)
  • median effective dose
    Á¤Áß À¯È¿·®(ïáñéêóüùÕá)
  • median hemolytic dose
    Á¤Áß ¿ëÇü·®(ïáñééÁúìÕá)
  • median immunizing dose
    Á¤Áß ¸é¿ª·®(ïáñéØóæµÕá)
  • median infectious dose
    Á¤Áß °¨¿°·®(ïáñéÊïæøÕá)
  • median lethal dose
    Á¤Áß Ä¡»ç·®(ïáñéöÈÞÝÕá)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lethal dose [=LD]
    Ä¡»ç·®
  • maintenance dose
    À¯Áö¿ë·®
  • maximal acceptable dose
    ÃÖ´ëÇã¿ë¼±·®
  • maximum permissible dose [=MPD]
    ÃÖ´ëÇã¿ë(¼±)·®
  • median lethal dose
    50%Ä¡»ç·®, Æò±ÕÄ¡»ç·®
  • midbreast dose
    À¯¹æÁß¾ÓÁ¶»ç¼±·®
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • permissible internal dose
    ³»ºÎÇã¿ë¼±·®
  • radiation absorbed dose
    ¶óµå, ¹æ»ç¼±Èí¼ö¼±·®
  • relative dose
    ºñ±³Á¶»ç·®, »ó´ëÁ¶»ç·®
  • single dose
    ÀÏȸ·®
  • skin dose
    ÇǺμ±·®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MCD magnetic circular dichroism; mast-cell degranulation; mean cell diameter; mean of consecutive differ...
MCV mean cell volume; mean clinical value; mean corpuscular volume; median cell volume; motor conduction...
MHD maintenance hemodialysis; mean hemolytic dose; mental health department; minimum hemolytic dilution;...
MPD main pancreatic duct; maximum permissible dose; mean population doubling; membrane potential differe...
MTD maximum tolerated dose; mean total dose; metastatic trophoblastic disease; Midwife Teacher's Diploma...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PTV Planning Target Volume
T Target
TCI Target Controlled Infusion
TH Target height
TLR Target lesion revascularization
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mean cell volume
    Æò±Õ ÀûÇ÷±¸ ¿ëÀû
  • mean corpuscular constant
    Æò±Õ ÀûÇ÷±¸ »ó¼ö
  • mean corpuscular hemoglobin
    ÀûÇ÷±¸ÀÇ Æò±Õ Ç÷»ö¼Ò·®
    MCH´Â ÀûÇ÷±¸ ÇÑ °³ ÇÑ °³°¡ °¡Áö´Â Ç÷»ö¼Ò·®ÀÇ Æò±ÕÄ¡¸¦ ¥ì¥ìg¶Ç´Â ¥ã¥ã·Î Ç¥½ÃÇÑ °Í.
  • mean corpuscular hemoglobin concentration
    ÀûÇ÷±¸ÀÇ Ç÷»ö¼Ò Æò±Õ ³óµµ, Æò±Õ ÀûÇ÷±¸ Ç÷»ö¼Ò ³óµµ
    MCHC´Â ÇÑ °³ ÇÑ °³ÀÇ ÀûÇ÷±¸°¡ °¡Áö´Â Ç÷»ö¼Ò ³óµµÀÇ Æò±ÕÀ» %·Î Ç¥½ÃÇÑ °Í.
  • mean corpuscular volume
    ÀûÇ÷±¸ÀÇ Æò±Õ ¿ëÀû, Æò±Õ ÀûÇ÷±¸ ¿ëÀû
    MCV´Â ÀûÇ÷±¸ ÇÑ °³ ÇÑ °³ÀÇ Æò±Õ ¿ëÀûÀ» ¥ì3À¸·Î Ç¥½ÃÇÑ °Í.
  • mean deviation
    Æò±Õ ÆíÂ÷
  • mean error
    Æò±Õ ¿ÀÂ÷
  • mean life expectancy
    Æò±Õ ¿©¸í
  • mean molecular weight
    Æò±Õ ºÐÀÚ·®
  • mean proportional
    ºñ·Ê ÁßÇ×
  • mean spatial vector
    Æò±Õ °ø°£
  • mean temperature
    Æò±Õ ¿Âµµ
  • mean value
    Æò±ÕÄ¡
  • weighted arithmetic mean
    °¡Áß »ê¼ú Æò±Õ
  • absorbed dose conversion factor
    Èí¼ö¼±·® º¯È¯ °è¼ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
geometric mean The mean calculated as the antilogarithm of the arithmetic mean of the logarithms of the individual values; it can also be calculated as the nth root of the product of n values.
(05 Mar 2000)
geometric mean diameter A measure of the central tendency of particle size composition of substrate materials sometimes used as an index of the quality of spawning gravels. Also referred to as D50 size.
(09 Oct 1997)
mean <statistics> Average value calculated by taking the sum of all values and dividing by the total number of values.
(05 Jan 1998)
mean annual increment The annual average growth rate for a tree, computed over its entire life cycle.
(05 Dec 1998)
mean arterial pressure <cardiology, physiology> The average value for arterial pressure. Systolic pressure + diastolic pressure divided by 2.
(27 Sep 1997)
mean calorie One hundredth of the energy required to raise the temperature of 1 g of water from 0°C to 100°C.
(05 Mar 2000)
mean corpuscular haemoglobin The haemoglobin content of the average red cell, calculated from the haemoglobin therein and the red cell count, in erythrocyte indices.
(05 Mar 2000)
mean corpuscular haemoglobin concentration Hgb/Hct;the average haemoglobin concentration in a given volume of packed red cells, calculated from the haemoglobin therein and the haematocrit, in erythrocyte indices.
(05 Mar 2000)
mean corpuscular volume The average volume of red cells, calculated from the haematocrit and the red cell count, in erythrocyte indices.
(05 Mar 2000)
mean electrical axis The average magnitude and direction of all the electromotive forces developed during the cardiac event under consideration; e.g., atrial or ventricular depolarisation, or ventricular repolarization.
See: axis deviation.
(05 Mar 2000)
mean foundation plane The mean of the various irregularities in form and inclination of the basal seat; the ideal condition for denture stability exists when the mean foundation plane is most nearly at right angles to the direction of force.
(05 Mar 2000)
mean free path <radiobiology> Average distance a particle travels between occurrences of the given event, for example, between collisions. For collisions, the mean free path is roughly equal to unity divided by the product of the collision cross-section times the particle density.
(09 Oct 1997)
mean higher high water <marine biology> The average height of the higher high water over a 19-year period. For shorter periods of observation, corrections are applied to eliminate known variations and reduce the result to the equivalent of a mean 19-year value.
(09 Oct 1997)
mean high water <marine biology> The average height of the high water over a 19-year period. For shorter periods of observation, corrections are applied to eliminate known variations and reduce the result to the equivalent of a mean 19-year value.
All high-waters heights are included in the average where the type of tide is either semidiurnal or mixed. Only the higher high-water heights are included in the average where the type of tide is diurnal. So determined, mean high water in the latter case is the same as mean higher high water.
(09 Oct 1997)
mean lower low water <marine biology> The average height of the lower low waters over a 19-year period. For shorter periods of observations, corrections are applied to eliminate known variations and reduce the result to the equivalent of a mean 19-year value.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mean sea level
    Æò±Õ ÇØ¸é(ÇØ¹ß ±âÁØ)
  • mean solar day
    Æò±Õ žçÀÏ
  • mean solar time
    Æò±Õ žç½Ã;Æò±Õ½Ã
  • mean sun
    Æò±Õ žç(õ±¸ÀÇ Àûµµ¸¦ Æò±Õ °¢¼Óµµ·Î ¿òÁ÷ÀÌ´Â °¡»ó žç)
  • root-mean-square
    Àڽ Æò±Õ Æò¹æ±Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á